If you're a health system CEO or CFO or COO or CPO, what's the one pharmacy trend you can no longer afford to ignore and you just have to look at investing in? To me,

I've been able to do a number of kind of assessments over this first half of the year.

So this is often where health systems may come to us at BSOT and say, hey, I think there's more we can get in pharmacy, but I'm not exactly sure where, not exactly sure to what degree, and I'm not exactly sure where I should start.

Or I've decided to make a transition to pharmacy as like a strategic partner or But I want to make sure I've got the structure of priorities, right? So we do a number of these types of engagements and in doing that work and sitting down with clients, to me, the area that continues to come up is we've built this ambulatory infusion program.

really strong.

It has its roots in oncology because that is where we started to deliver ambulatory infusion.

And there hasn't been a whole lot of strategic thought that has gone into the areas outside of oncology.

And so I think there's definitely a difference between how those two health systems focus, and it's usually the health systems where they see pharmacy as an integral part of enterprise strategy, where they're able to maximize their success, not just in revenue management, but also patient care.